Gracell Biotechnologies Inc. GRCL

Full chart Compare
Set alert

Price alert · GRCL

All alert types
10.25 0.00 (+0.00%)

At closeFeb 21, 2024, 4:00 PM EST

10.17 Day range 10.28

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $7.76MOther Operating Income → Expenses: $9.12MExpenses → Selling, General & Admin: $137.04MExpenses → Research & Development: $326.90MExpenses → Interest Expense: $5.06MGross Profit → Expenses: $366.00KRevenue → Gross Profit: $366.00KNet Loss → Expenses: $451.75MOther Income$7.76MOther Operating Income$9.12MGross Profit$366.00KNet Loss$451.75MExpenses$469.00MSelling, General & Admin$137.04MResearch & Development$326.90MInterest Expense$5.06MRevenue$366.00K

Latest period ending Dec 31, 2022 · select a line to chart its full history

GRCL annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-616.66M-454.45M-209.69M-145.13M-62.25M
-607.51M-451.75M-211.90M-138.66M-60.79M
-9.00-6.90-13.85-10.15-3.65
GRCL annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
1.45B1.83B754.31M312.06M11.89M
1.66B2.06B964.95M412.22M148.52M
280.51M232.77M145.29M156.86M146.13M
182.98M155.18M102.89M138.69M138.69M
1.38B1.83B-587.87M-292.49M-81.02M
GRCL annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-482.65M-304.55M-198.15M-135.39M-61.86M
-48.33M-41.62M-93.94M41.37M-113.36M
33.32M1.46B756.47M394.80M138.69M
-48.39M-56.74M-79.40M-56.43M-11.36M
-374.36M1.07B442.25M300.17M-36.52M